Verily lures major pharmas with promise of speedier clinical research

Seeking more efficient clinical research, four major drugmakers have partnered with Alphabet's life sciences-focused subsidiary Verily, announcing Tuesday early details of collaborations aimed at driving trial recruitment and speeding generation of clinical evidence.